Video Player is loading.

Up next


Dr Yeadon former Chief Scientific Officer with Pfizer openly tells about covid-19 testing fraud and covid-19 fraud.

Times of Truth
Times of Truth - 1,152 Views
281
1,152 Views
Published on 05 Oct 2020 / In People and Blogs

We are basing a government policy, an economic policy , a civil liberties policy, in terms of limiting people to six-seven in a meeting…all based on, what well be completely fake data on the coronavirus?

And Dr. Yeadon former Chief Scientific Officer replies to this question with “YES” ; i.e. all most all covid testing results are false positives and data is a fraud.

About
Dr. Yeadon is an Allergy & Respiratory Therapeutic Area expert, developed out of deep knowledge of biology & therapeutics and is an innovative drug discoverer with 23years in the pharmaceutical industry.
He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988 on the CNS and peripheral pharmacology of opioids on respiration.

Dr Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.

Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. During his tenure at Pfizer, Dr Yeadon was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.

Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva® and acquisition of the Meridica (inhaler device) company.

Dr Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.

Show more
0 Comments sort Sort by

Up next